Study: Pharmas back market access efforts from Phase IIIa to post-launch

mia.burns By Mia Burns Pharmas tend to focus attention on market research in Phase IIIa to market approval and on health economics and outcomes research from launch to six months post-launch, ...

Soligenix Completes Phase 1 Clinical Study with SGX203 for the Treatment of Pediatric Crohn’s Disease

barbara.lempert Princeton, NJ – June 28, 2013 – Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing ...

Veloxis Announces Positive Results of 3002 Study: LCP-Tacro Meets Primary Efficacy and Safety Endpoints in de Novo Kidney Transplant Patients

barbara.lempert – LCP-Tacro™, once-daily, demonstrated non-inferiority to Prograf®, twice-daily, based on the composite endpoint of treatment failure at one year (LCP-Tacro™ ...

Medivation, Astellas Start Phase II Breast Cancer Study

barbara.lempert Medivation and Astellas Initiate Phase 2 Study of Enzalutamide in Breast Cancer Patients SAN FRANCISCO, CA and TOKYO — (Marketwired) — 06/26/13 — ...

Initiation of Volitinib China Phase I study triggers US$5 million milestone payment

barbara.lempert Hutchison China MediTech Limited (“Chi-Med”) (AIM: HCM) Initiation of Volitinib China Phase I study triggers US$ 5 million milestone payment; Australia Phase I ...

Upsher-Smith Announces Patient Enrollment In Open-label Safety Study Of USL261

barbara.lempert Upsher-Smith Announces Patient Enrollment In Open-label Safety Study Of USL261 (Intranasal Midazolam) For Rescue Treatment Of Seizure Clusters In Epilepsy Extension ...

Glaxo’s diabetes drug fails to beat Takeda’s Actos in head-to-head study

Ryan McBride CHICAGO–GlaxoSmithKline's experimental diabetes drug proved to be at least as good at controlling blood sugar as most–but not one–in a series of late-stage ...

Kantar Media study outlines KOL digital media usage

mia.burns By Mia Burns A new study has shown that key opinion leaders, who are physicians who influence their peers’ medical practice decisions, are far more digitally-savvy. The ...

Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published

barbara.lempert Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine SUNNYVALE, Calif., June 19, 2013 /PRNewswire/ ...

Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published

barbara.lempert Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine SUNNYVALE, Calif., June ...

Study: 70% of Americans Are On Prescription Drugs

barbara.lempert Germ fighters, antidepressants, opioids top list; women, elderly likelier to have prescriptions ROCHESTER, Minn., June 19, 2013 — Nearly 70 percent of Americans ...

Sarepta shares spike on upbeat results from DMD extension study

John Carroll Shares of Sarepta were boosted this morning after the biotech announced that it reaped another round of promising results from a closely-watched Phase IIb study of its ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS